Preoperative PET cuts
unnecessary lung surgeries in half
PET changed patient
management in 50 percent of lung cancer cases, a comprehensive statistical
analysis reveals. Few studies have been able to pin down exactly what impact
preoperative PET has on clinical decision-making and resulting treatment.
Preliminary review of the data from this long-term, observational study was
inconclusive, but after a more thorough statistical analysis accounting for
selection bias and other confounding factors, the researchers were able to
conclude that PET imaging eliminated approximately half of unnecessary
surgeries.
New quantitative data
suggests that 30 percent of the surgeries performed for non-small cell lung
cancer patients in a community-wide clinical study were deemed unnecessary.
Additionally, positron emission tomography (PET) was found to reduce
unnecessary surgeries by 50 percent, according to research published in the
March issue of the Journal of Nuclear Medicine.
PET imaging prior to surgery helps stage a patient's disease by
providing functional images of tumors throughout the body, especially areas
where cancer has spread, otherwise known as metastasis. Few studies have been
able to pin down exactly what impact preoperative PET has on clinical
decision-making and resulting treatment. Preliminary review of the data from
this long-term, observational study of an entire community of veterans was
inconclusive about the utility of PET, but after a more thorough statistical
analysis accounting for selection bias and other confounding factors, the
researchers were able to conclude that PET imaging eliminated approximately
half of unnecessary surgeries.
"It has become standard of care for lung cancer patients to
receive preoperative PET imaging," said Steven Zeliadt, PhD, lead author
of the study conducted at VA Puget Sound Health Care System and associate
professor for the University of Washington in Seattle, Wash. "The
prevailing evidence reinforces the general understanding within the medical
community that PET is very useful for identifying occult metastasis and that it
helps get the right people to surgery while avoiding unnecessary surgeries for
those who would not benefit."
For this study, researchers reviewed newly diagnosed non-small
lung cancer patients who received preoperative PET to assess the real-life
effectiveness of PET as a preventative measure against unnecessarily invasive
treatment across a community of patients. A total of 2,977 veterans who
underwent PET during disease staging from 1997 to 2009 were included in the
study. Of these, 976 patients underwent surgery to respect their lung cancer.
During surgery or within 12 months of surgery, 30 percent of these patients
were found to have advanced-stage metastatic disease, indicating an unnecessary
surgery.
Interestingly, the use of PET increased during the study period
from 9% to 91%. Conventional multivariate analyses was followed by instrumental
variable analyses to account for unobserved anomalies, such as when patients
did not undergo PET when it would have been clinically recommended to do so.
This new data has the potential to change policy and recommendations regarding
the use of oncologic PET for more accurate tumor staging.
"We will likely build more quality measures around this
research so that preoperative PET is more strongly recommended to improve the
management of care for these patients," added Zeliadt.